GlaxoSmithKline

Buy GlaxoSmithKline If It Rises Above $45

Applying The Venture Capital Model To Public Companies: Hugh Cleland

BASF to fatten up nutrition arm

VIVUS rallies after Aetna revises obesity drug policy

FDA Approves PROMACTA® (Eltrombopag) For The Treatment Of Thrombocytopenia In Patients With Chronic Hepatitis C

Week of November 19, 2012: German Court Finds AstraZeneca's Seroquel XR Formulation Patent Invalid; FDA Advisory Committee to Recommend Approval of GSK's H5N1 Influenza Vaccine Candidate; and More

Palace to host UK trade fair

Ligand Pharmaceuticals (LGND) Closed Challenging The Highs

Ligand soars on GSK win for new Promacta use in HCV patients

Regulus Therapeutics' CEO Discusses Q3 2012 Results - Earnings Call Transcript